Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that the first set of abstracts have been released from several studies that will be shared at the ...

New mid-stage data reported at the 2020 virtual ASCO meeting suggest that the HER2-targeting antibody-drug conjugate (ADC) can achieve meaningful clinical responses in patients with HER2- positive ...

Adjuvant ado-trastuzumab emtansine improved survival compared with trastuzumab for early HER2-positive breast cancer. Long-term follow-up showed a continued DFS benefit with ado-trastuzumab ...

If you prefer non-medicated treatments, the gel cap from TheraICE is a next-level option that molds to your entire head and is completely reusable. The stretchy hat provides both hot and cold ...

The acquittal of a man charged with the murder of Rift Valley Institute of Science and Technology (RVIST) lecturer has put three pathologists on the spot. This is after the autopsy report raised ...

These courses will, when considered collectively, familiarize students with central concepts and texts of the Catholic intellectual tradition. The CAP program will contain two writing courses, a first ...

We are tackling every major issue facing the world today, from fighting malaria and infections, to antimicrobial resistance, climate change and the ecology of our planet. Explore the breadth of our ...

Commissions do not affect our editors' opinions or evaluations. Small-cap stocks offer big advantages for your investment portfolio. Nimble, small companies grow faster than large-cap firms ...

Introduction: Metastatic rhabdomyosarcoma (RMS) is a challenging tumor entity that evades conventional treatments and endogenous antitumor immune responses, highlighting the need for novel therapeutic ...

The American Society of Clinical Oncology (ASCO) has released updated guidelines on the use of biomarkers in early-stage breast cancer. The new guidelines now recommend the use of Breast Cancer Index ...